<DOC>
	<DOCNO>NCT01166048</DOCNO>
	<brief_summary>Objective : The objective study compare efficacy duloxetine treatment patient chronic low back pain radicular component placebo . Study hypothesis : Duloxetine new substance use treatment neuropathic pain . It proven efficacy diabetic peripheral neuropathy fibromyalgia several trial . The investigator therefore hypothesize duloxetine efficacious patient chronic low back pain radicular component . Study Rationale : Chronic low back pain extremely common diagnosis . However , therapeutic option condition limit therapy remain difficult . Duloxetine proven efficacy patient neuropathic pain may also useful chronic low back pain . If investigator able show benefit patient duloxetine arm , substance may constitute treatment alternative chronic low back pain . Study Design : Prospective , randomize , double-blind placebo-controlled cross study . Patients administer duloxetine 4 week follow 2 week wash-out phase medicate placebo 4 week . A second group patient receive medication reverse order . The primary study endpoint constitute weekly mean VAS-Score last week treatment period . Secondary endpoint define use rescue medication , Beck Depression Inventory score , Health relate Quality Life SF-36 score side effects/adverse event .</brief_summary>
	<brief_title>Comparison Efficacy Duloxetine With Placebo Patients With Chronic Low Back Pain With Radicular Component</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Low back pain ( L1 ) Chronic pain , &gt; 6 month Visual Analogue Scale ( VAS ) ≥ 5 Back pain radicular component define pain burning , tingle sensation within anatomic distribution nerve root diagnose painDETECT questionnaire Failed back surgery Current mood disorder ( dysthymia , bipolar mood disorder ) Major Depression &gt; 12 month ( Beck Depression Inventory Score ≥ 18 ) History psychoactive substance use disorder within precede 12 month Major coexist medical illness ( e.g . severe heart failure , pulmonary hypertension , renal insufficiency ) Glaucoma Acute myocardial infarction uncontrolled hypertension Prostate hyperplasia History convulsion Pregnancy ; woman childbearing age require use contraceptive duration study . Furthermore pregnancy test perform prior begin study month study period . Participation clinical trial 3 week precede study Allergy study medication Use follow medication : opioids except tramadol , benzodiazepine indicate low dos sleep disorder antineuropathic medication include except specify study protocol muscle relaxant antidepressant indicate low dos sleep disorder NSAID , Paracetamol nonselective MAOInhibitors Fluvoxamine , Ciprofloxacin , Enoxacin Selective Serotoninreuptake Inhibitors ( SSRI ) taper drug impossible inclusion . Impaired kidney function ( Creatinine &gt; 1.5mg/dl ) Impaired hepatic function ( GOT , GPT &gt; 2 fold standard level ) Patients able understand study measure able complete pain assessment form .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Chronic Low Back Pain</keyword>
	<keyword>Radicular component</keyword>
	<keyword>neuropathic pain</keyword>
	<keyword>duloxetine</keyword>
	<keyword>CLBP</keyword>
</DOC>